Genetic test identifies invasive lobular carcinomas that are at high risk of recurring

(European Organisation for Research and Treatment of Cancer) New results to be presented at the 12th European Breast Cancer Conference show that a test, which looks at the activity of 70 genes in breast cancer tissue, is possible to use in the clinic to identify patients with invasive lobular carcinoma (ILC) that is at high risk of recurring and progressing.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news